Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world.
“Timely diagnosis and treatment of stroke should not be limited to urban areas and comprehensive stroke centres,” said Blackford founder and CEO Ben Panter. “Adding Brainomix’s AI-powered e-Stroke to the Blackford Platform allows more institutions around the world to accelerate transfer and treatment times, and expand access to critical endovascular therapy for their patients.”
Brainomix’s AI-powered e-Stroke tools can utilise images from non-contrast or contrast-enhanced computed tomography (CT) exams to provide physicians fast, effective and accurate analysis of images that expedite treatment decisions. Combined with the e-Stroke mobile app, physicians can quickly and securely access, review and share patient images and data to optimise workflow, and facilitate faster transfer and treatment decisions, as per a company press release.
“We are very excited to launch this partnership with Blackford—a company that has firmly established itself as a leading provider of tailored, best-in-class medical imaging and AI-powered solutions that deliver clinical value, with an extensive customer base and a highly regarded focus on technical excellence,” said Michalis Papadakis, CEO and co-founder at Brainomix. “With our e-Stroke platform, we believe that we have the opportunity to work together to provide physicians with the most comprehensive stroke AI imaging solution, shown to optimise networks and ultimately improve patient outcomes.”
